Nuveen LLC Invests $3.37 Million in Astrana Health, Inc. $ASTH

Key Points

• Nuveen LLC has acquired 108,638 shares in Astrana Health, Inc. for approximately $3.37 million, representing a new position of about 0.19% ownership in the company.
• Institutional investors collectively own 52.77% of Astrana Health's stock, highlighting significant interest from various funds, including Vanguard Group and Dimensional Fund Advisors.
• Astrana Health reported $0.19 EPS for the most recent quarter, falling short of the consensus estimate of $0.36, despite a 34.7% year-over-year revenue increase to $654.81 million.

Nuveen LLC bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 108,638 shares of the company's stock, valued at approximately $3,369,000. Nuveen LLC owned 0.19% of Astrana Health at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of ASTH. Quarry LP lifted its holdings in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares in the last quarter. Covestor Ltd raised its position in Astrana Health by 777.6% in the 1st quarter. Covestor Ltd now owns 2,001 shares of the company's stock valued at $62,000 after buying an additional 1,773 shares during the last quarter. US Bancorp DE raised its position in Astrana Health by 21.3% in the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock valued at $180,000 after buying an additional 1,015 shares during the last quarter. PharVision Advisers LLC acquired a new stake in Astrana Health in the 4th quarter valued at approximately $211,000. Finally, Envestnet Asset Management Inc. raised its position in Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after buying an additional 1,184 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Stock Up 2.0%

Astrana Health stock traded up $0.63 during midday trading on Monday, reaching $31.96. The stock had a trading volume of 358,021 shares, compared to its average volume of 487,013. The firm's fifty day simple moving average is $25.91 and its 200-day simple moving average is $28.34. Astrana Health, Inc. has a 1-year low of $21.20 and a 1-year high of $63.20. The stock has a market capitalization of $1.79 billion, a P/E ratio of 62.67, a price-to-earnings-growth ratio of 0.79 and a beta of 0.84. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The firm had revenue of $654.81 million during the quarter, compared to analyst estimates of $639.13 million. During the same period in the prior year, the business posted $0.40 EPS. The firm's quarterly revenue was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. As a group, analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.